SCICLONE PHARMACEUTICALS INC: accounts_receivable
| Value | {"amount": 36974000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-09-30) |
| Status | superseded |
| Entity | SCICLONE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/416bf7a8-1b76-4017-a8e4-9b49fa154272
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-463541Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000880771/accounts-receivable/2012-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/416bf7a8-1b76-4017-a8e4-9b49fa154272
History
- no predecessors — first report